deferoxamine has been researched along with Pancytopenia in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
Excerpt | Relevance | Reference |
---|---|---|
"Pancytopenia is difficult to manage in patients with this disorder." | 1.32 | Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin. ( Erduran, E; Hacisalihoglu, S; Ozoran, Y, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erduran, E | 1 |
Hacisalihoglu, S | 1 |
Ozoran, Y | 1 |
Ammon, A | 1 |
Rumpf, KW | 1 |
Hommerich, CP | 1 |
Behrens-Baumann, W | 1 |
RĂ¼chel, R | 1 |
2 other studies available for deferoxamine and Pancytopenia
Article | Year |
---|---|
Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin.
Topics: Blood Cell Count; Bone Marrow; Child, Preschool; Deferoxamine; Disease Susceptibility; Dyskeratosis | 2003 |
[Rhinocerebral mucormycosis during deferoxamine therapy].
Topics: Adult; Blindness; Brain Diseases; Cellulitis; Combined Modality Therapy; Deferoxamine; Female; Human | 1992 |